Theralizumab
Product Specifications
CAS Number
906068-56-2
Target
Others|||Immunology/Inflammation related
Related Pathways
Others|||Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E12410 1 Unit/Pack
Swirlex-Digital Hand Held Homogenizer with Dispersing shaft Suporting for volume 0.1-50 ml & Support Stand. - ABDOS
Ask
View Details 
GTR15307224 1 Vial
Lentiviral human C15orf40 shRNA (UAS) - Lentiviral human C15orf40 shRNA (UAS, GFP) (100)
Ask
View Details